StonvexLoading…
StonvexStonvexStonvexCore line items from CSBR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-04-30 | Annual 2024 2024-04-30 | Annual 2023 2023-04-30 | Annual 2022 2022-04-30 |
|---|---|---|---|---|
Revenue | $56.94M | $50.16M | $53.87M | $49.11M |
Operating Income | $4.55M | $-7.36M | $-5.26M | $607.00K |
Net Income | $4.70M | $-7.28M | $-5.33M | $548.00K |
EPS (Diluted) | $0.33 | $-0.54 | $-0.39 | $0.04 |
Total Assets | $32.34M | $26.13M | $34.31M | $35.38M |
Total Liabilities | $28.57M | $28.04M | $29.68M | $26.28M |
Cash & Equivalents | $9.79M | $2.62M | $10.12M | $9.01M |
Free Cash Flow OCF − CapEx | $7.00M | $-6.97M | $1.10M | $4.11M |
Shares Outstanding | 13.78M | 13.59M | 13.54M | 13.52M |